| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Rodney S Markin is Director at CRDF. Rodney S Markin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $21K at current prices.
Net of sales, the CRDF filings show accumulation of 65,079 shares.
Rodney S Markin has 18 Form 4 filings on record from March 2015 to June 2026, all as Director at Cardiff Oncology (CRDF), 2015–2026.
The 18 reported transactions were 13 option or other derivative awards, 3 open-market purchases and 2 option exercises.
Counted by filing, the open-market trades come to 3 purchases worth about $95K and no sales.
The largest open-market purchase was 41,200 shares of CRDF at an average $0.85 on June 20, 2018, about $35K.